$PDSB
PDS Biotechnology Corporation
PRICE
$4.8 โผ-3.808%
Extented Hours
VOLUME
178,454
DAY RANGE
5.26 - 5.65
52 WEEK
2.91 - 17.85
Key Metrics
Market Cap
159.37 M
Beta
2.07
Avg. Volume
297.01 K
Shares Outstanding
28.46 M
Yield
0%
Public Float
0
Next Earnings Date
2022-11-09
Next Dividend Date
Company Information
PDS Biotech is a clinical-stage immunotherapy company with a growing pipeline of cancer immunotherapies and infectious disease vaccines based on the Company's proprietary Versamuneยฎ T-cell activating technology platform. Versamuneยฎ effectively delivers disease-specific antigens for in vivo uptake and processing, while also activating the critical type 1 interferon immunological pathway, resulting in production of potent disease-specific killer T-cells as well as neutralizing antibodies. PDS Biotech has engineered multiple therapies, based on combinations of Versamuneยฎ and disease-specific antigens, designed to train the immune system to better recognize disease cells and effectively attack and destroy them.
CEO: Frank Bedu-Addo
Website: www.pdsbiotech.com
HQ: 25B Vreeland Road Florham Park, 07932 New Jersey
Related News